Related Articles
Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line
Effect of bortezomib in combination with cisplatin and 5‑fluorouracil on 4T1 breast cancer cells
A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomib
Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)
Induction of tumor cell apoptosis by taurine Schiff base copper complex is associated with the inhibition of proteasomal activity